Всесоюзный научно-исследовательский институт химии и технологии лекарственных средств
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Всесоюзный научно-исследовательский институт химии и технологии лекарственных средствfiledCriticalВсесоюзный научно-исследовательский институт химии и технологии лекарственных средств
Priority to SU4226719/14ApriorityCriticalpatent/SU1518949A1/en
Application grantedgrantedCritical
Publication of SU1518949A1publicationCriticalpatent/SU1518949A1/en
FIELD: chemical and pharmaceutical industry. SUBSTANCE: mixture of propylene glycol and ethanol is added to 5-ethoxy-2-ethylthiobenzimidazole chlorohydrate and stirred up to dissolving. Then sodium acetate in 0.1% acetic acid and water for injection were added. Prepared solution is filtered, ampoulized and sterilized. EFFECT: increased stability for 24 months. 1 tbl
SU4226719/14A1987-04-091987-04-09Method of preparing of 5-ethoxy-2-ethylthiobenzimidazole injection solution
SU1518949A1
(en)
7-Methoxy-5-oxo-5H-thiazolo(2,3-b)quinazolin-2-carboxylic acid and its pharmaceutically acceptable salts, process for their preparation and medicines containing them.
AMINOPROPANOL DERIVATIVES OF 6-HYDROXY-2,3,4,5-TETRAHY DRO-1H-1-BENZAZEPINE-2-ONE, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
N-METHYL-D-GLUCAMINE SALT OF 3,4-DIHYDRO-5-METHYL-6- (2-METHYL-PROPYL) -4-OXOTIENO (2,3-D) PYRIMIDIN-2-CARBOXYLIC ACID AND PHARMACEUTICAL COMPOSITION CONTAINING THIS SALT